{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T19:21:00Z","timestamp":1790364060178,"version":"4.1.0"},"reference-count":89,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T00:00:00Z","timestamp":1776902400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003136","name":"Edmond J. Safra Philanthropic Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003136","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003579","name":"University of Toronto","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003579","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019829","name":"Centre for Aging + Brain Health Innovation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100019829","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009307","name":"Parkinson Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009307","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008444","name":"Parkinsonfonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008444","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100022764","name":"Rossy Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100022764","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000864","name":"Michael J. Fox Foundation for Parkinson's Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000864","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jamda.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Medical Directors Association"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.jamda.2026.106285","type":"journal-article","created":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T09:20:47Z","timestamp":1780910447000},"page":"106285","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Paratonia in Advanced Dementia: Deconstructing Scientific, Regulatory, and Health System Barriers to Botulinum Toxin A (BoNT-A) Treatment of Involuntary Muscle Resistance"],"prefix":"10.1016","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5261-2509","authenticated-orcid":false,"given":"Galit","family":"Kleiner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony E.","family":"Lang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jamda.2026.106285_bib1","first-page":"54","article-title":"D\u00e9bilit\u00e9 mentale et d\u00e9bilit\u00e9 motrice associ\u00e9es","volume":"20","author":"Dupr\u00e9","year":"1910","journal-title":"Rev Neurol"},{"key":"10.1016\/j.jamda.2026.106285_bib2","first-page":"377","article-title":"Gegenhalten (motorischer Negativismus), Zwangsgreifen und Thalamus opticus","volume":"65","author":"Kleist","year":"1927","journal-title":"Monatsschr Psychiatr Neurol"},{"key":"10.1016\/j.jamda.2026.106285_bib3","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1519\/00139143-200608000-00002","article-title":"Paratonia: a Delphi procedure for consensus definition","volume":"29","author":"Hobbelen","year":"2006","journal-title":"J Geriatr Phys Ther"},{"key":"10.1016\/j.jamda.2026.106285_bib4","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1111\/j.1532-5415.1999.tb07240.x","article-title":"Equilibrium and limb coordination in mild cognitive impairment and mild Alzheimer's disease","volume":"47","author":"Franssen","year":"1999","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.jamda.2026.106285_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.exger.2020.111125","article-title":"The role of inflammaging and advanced glycation end products on paratonia in patients with dementia","volume":"142","author":"Drenth","year":"2020","journal-title":"Exp Gerontol"},{"key":"10.1016\/j.jamda.2026.106285_bib6","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1177\/1533317518760594","article-title":"Paratonia in Flemish nursing homes: current state of practice","volume":"33","author":"Van Deun","year":"2018","journal-title":"Am J Alzheimers Dis Other Demen"},{"key":"10.1016\/j.jamda.2026.106285_bib7","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1176\/ajp.139.9.1136","article-title":"The Global Deterioration Scale for assessment of primary degenerative dementia","volume":"139","author":"Reisberg","year":"1982","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.jamda.2026.106285_bib8","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1017\/S1041610210002449","article-title":"Prevalence, incidence and risk factors of paratonia in patients with dementia: a one-year follow-up study","volume":"23","author":"Hobbelen","year":"2011","journal-title":"Int Psychogeriatr"},{"key":"10.1016\/j.jamda.2026.106285_bib9","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1177\/089198879701000301","article-title":"Neuromotor changes in Alzheimer's disease: implications for patient care","volume":"10","author":"Souren","year":"1997","journal-title":"J Geriatr Psychiatry Neurol"},{"key":"10.1016\/j.jamda.2026.106285_bib10","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1097\/WNF.0000000000000441","article-title":"Trazodone treatment of bruxism in a patient with severe dementia","volume":"44","author":"Stewart","year":"2021","journal-title":"Clin Neuropharmacol"},{"key":"10.1016\/j.jamda.2026.106285_bib12","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1177\/153331750201700411","article-title":"Evidence and mechanisms of retrogenesis in Alzheimer's and other dementias: management and treatment import","volume":"17","author":"Reisberg","year":"2002","journal-title":"Am J Alzheimers Dis Other Demen"},{"key":"10.1016\/j.jamda.2026.106285_bib13","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jns.2009.08.034","article-title":"The epidemiology of dementia associated with Parkinson disease","volume":"289","author":"Aarsland","year":"2010","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.jamda.2026.106285_bib14","article-title":"2025 Alzheimer's disease facts and figures","volume":"21","year":"2025","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.jamda.2026.106285_bib15","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1002\/alz.12362","article-title":"Population estimate of people with clinical Alzheimer's disease and mild cognitive impairment in the United States (2020-2060)","volume":"17","author":"Rajan","year":"2021","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.jamda.2026.106285_bib16","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1001\/jama.287.16.2090","article-title":"Patient and caregiver characteristics and nursing home placement in patients with dementia","volume":"287","author":"Yaffe","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.jamda.2026.106285_bib17","first-page":"26","article-title":"Are joint contractures in patients with Alzheimer's disease preventable?","volume":"18","author":"Jamshed","year":"2010","journal-title":"Ann Long Term Care"},{"key":"10.1016\/j.jamda.2026.106285_bib18","first-page":"45","article-title":"Urinary tract infections. How to manage nursing home patients with or without chronic catheterization","volume":"57","author":"O'Donnell","year":"2002","journal-title":"Geriatrics"},{"key":"10.1016\/j.jamda.2026.106285_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijnurstu.2023.104605","article-title":"Prevalence and incidence of pressure injuries among older people living in nursing homes: a systematic review and meta-analysis","volume":"148","author":"Sugathapala","year":"2023","journal-title":"Int J Nurs Stud"},{"key":"10.1016\/j.jamda.2026.106285_bib20","first-page":"1","article-title":"Pressure ulcers among nursing home residents: United States, 2004","volume":"14","author":"Park-Lee","year":"2009","journal-title":"NCHS Data Brief"},{"key":"10.1016\/j.jamda.2026.106285_bib21","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.3389\/fphar.2019.01045","article-title":"Antipsychotic treatment of behavioral and psychological symptoms of dementia (BPSD): management of extrapyramidal side effects","volume":"10","author":"Ohno","year":"2019","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jamda.2026.106285_bib22","article-title":"Don't use antipsychotics as first choice to treat behavioral and psychological symptoms of dementia","year":"2013","journal-title":"Am Geriatr Soc"},{"key":"10.1016\/j.jamda.2026.106285_bib23","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1056\/NEJMoa0902234","article-title":"The clinical course of advanced dementia","volume":"361","author":"Mitchell","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jamda.2026.106285_bib24","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1002\/ejp.523","article-title":"Impact of a stepwise protocol for treating pain on pain intensity in nursing home patients with dementia: a cluster randomized trial","volume":"18","author":"Sandvik","year":"2014","journal-title":"Eur J Pain"},{"key":"10.1016\/j.jamda.2026.106285_bib25","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1016\/j.jpainsymman.2020.10.011","article-title":"Pain in dementia: prevalence and association with neuropsychiatric behaviors","volume":"61","author":"Atee","year":"2021","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.jamda.2026.106285_bib26","doi-asserted-by":"crossref","first-page":"935","DOI":"10.2147\/CIA.S161052","article-title":"Tolerability of buprenorphine transdermal system in nursing home patients with advanced dementia: a randomized, placebo-controlled trial (DEP.PAIN.DEM)","volume":"13","author":"Erdal","year":"2018","journal-title":"Clin Interv Aging"},{"key":"10.1016\/j.jamda.2026.106285_bib27","article-title":"Effects of rich cannabidiol oil on behavioral disturbances in patients with dementia: a placebo controlled randomized clinical trial","volume":"9","author":"Hermush","year":"2022","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.jamda.2026.106285_bib28","author":"Aisen"},{"key":"10.1016\/j.jamda.2026.106285_bib29","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.3233\/JAD-200691","article-title":"Paratonia in dementia: a systematic review","volume":"78","author":"Drenth","year":"2020","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.jamda.2026.106285_bib30","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1017\/S1041610211002468","article-title":"Passive movement therapy in severe paratonia: a multicenter randomized clinical trial","volume":"24","author":"Hobbelen","year":"2012","journal-title":"Int Psychogeriatr"},{"key":"10.1016\/j.jamda.2026.106285_bib31","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1080\/09638280010029930","article-title":"Contractures in orthopaedic and neurological conditions: a review of causes and treatment","volume":"23","author":"Farmer","year":"2001","journal-title":"Disabil Rehabil"},{"key":"10.1016\/j.jamda.2026.106285_bib32","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1152\/japplphysiol.00278.2018","article-title":"Muscle contracture and passive mechanics in cerebral palsy","volume":"126","author":"Lieber","year":"2019","journal-title":"J Appl Physiol (1985)"},{"key":"10.1016\/j.jamda.2026.106285_bib33","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.3390\/jpm11111074","article-title":"Effectiveness of stretching in post-stroke spasticity and range of motion: systematic review and meta-analysis","volume":"11","author":"Gomez-Cuaresma","year":"2021","journal-title":"J Pers Med"},{"key":"10.1016\/j.jamda.2026.106285_bib34","doi-asserted-by":"crossref","first-page":"11","DOI":"10.2522\/ptj.20100265","article-title":"Effectiveness of stretch for the treatment and prevention of contractures in people with neurological conditions: a systematic review","volume":"91","author":"Katalinic","year":"2011","journal-title":"Phys Ther"},{"key":"10.1016\/j.jamda.2026.106285_bib35","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.parkreldis.2019.02.035","article-title":"A randomized study of botulinum toxin versus botulinum toxin plus physical therapy for treatment of cervical dystonia","volume":"63","author":"Hu","year":"2019","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.jamda.2026.106285_bib36","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/S0161-6420(80)35127-0","article-title":"Botulinum toxin injection into extraocular muscles as an alternative to strabismus surgery","volume":"87","author":"Scott","year":"1980","journal-title":"Ophthalmology"},{"issue":"Suppl 4","key":"10.1016\/j.jamda.2026.106285_bib37","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1468-1331.2006.01652.x","article-title":"Safety and efficacy of botulinum toxin type A following long-term use","volume":"13","author":"Naumann","year":"2006","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.jamda.2026.106285_bib38","doi-asserted-by":"crossref","first-page":"249","DOI":"10.3390\/toxins5020249","article-title":"Long-term efficacy and safety of botulinum toxin injections in dystonia","volume":"5","author":"Ramirez-Castaneda","year":"2013","journal-title":"Toxins (Basel)"},{"key":"10.1016\/j.jamda.2026.106285_bib40","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1111\/j.1526-4610.2010.01678.x","article-title":"OnabotulinumtoxinA for treatment of chronic migraine: pooled results from the double-blind, randomized, placebo-controlled phases of the PREEMPT clinical program","volume":"50","author":"Dodick","year":"2010","journal-title":"Headache"},{"key":"10.1016\/j.jamda.2026.106285_bib41","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1056\/NEJMoa011892","article-title":"Intramuscular injection of botulinum toxin for the treatment of wrist and finger spasticity after a stroke","volume":"347","author":"Brashear","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jamda.2026.106285_bib42","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/S1474-4422(15)00216-1","article-title":"Safety and efficacy of abobotulinumtoxinA for hemiparesis in adults with upper limb spasticity after stroke or traumatic brain injury: a double-blind randomised controlled trial","volume":"14","author":"Gracies","year":"2015","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.jamda.2026.106285_bib43","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.pmrj.2017.12.006","article-title":"OnabotulinumtoxinA for the treatment of poststroke distal lower limb spasticity: a randomized trial","volume":"10","author":"Wein","year":"2018","journal-title":"PM R"},{"key":"10.1016\/j.jamda.2026.106285_bib44","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1212\/WNL.0000000000003789","article-title":"Safety and efficacy of incobotulinumtoxinA doses up to 800 U in limb spasticity: the TOWER study","volume":"88","author":"Wissel","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.jamda.2026.106285_bib45","doi-asserted-by":"crossref","first-page":"420","DOI":"10.3390\/toxins16100420","article-title":"SYNCHRONIZE: real-world retrospective safety analysis of patients treated with OnabotulinumtoxinA for more than one therapeutic indication","volume":"16","author":"Forde","year":"2024","journal-title":"Toxins (Basel)"},{"key":"10.1016\/j.jamda.2026.106285_bib46","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.jamda.2012.03.005","article-title":"Can botulinum toxin decrease carer burden in long term care residents with upper limb spasticity? A randomized controlled study","volume":"13","author":"Lam","year":"2012","journal-title":"J Am Med Dir Assoc"},{"key":"10.1016\/j.jamda.2026.106285_bib47","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0114733","article-title":"A randomized, placebo controlled pilot trial of botulinum toxin for paratonic rigidity in people with advanced cognitive impairment","volume":"9","author":"Kleiner-Fisman","year":"2014","journal-title":"PLoS One"},{"issue":"suppl 1","key":"10.1016\/j.jamda.2026.106285_bib48","article-title":"Botulinum toxin A treatment for disabling paratonia in advanced dementia: a retrospective chart review poster presented at: International Neurotoxin Association Meeting (Toxins 2026); January 14\u201317, 2026; Madrid, Spain","volume":"271","author":"Kleiner","year":"2026","journal-title":"Toxicon"},{"key":"10.1016\/j.jamda.2026.106285_bib49","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1080\/14740338.2021.1915282","article-title":"Long-term efficacy and safety of botulinum toxin treatment for cervical dystonia: a critical reappraisal","volume":"20","author":"Marsili","year":"2021","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/j.jamda.2026.106285_bib50","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1212\/WNL.0000000000002560","article-title":"Practice guideline update summary: botulinum neurotoxin for the treatment of blepharospasm, cervical dystonia, adult spasticity, and headache [RETIRED]: report of the guideline development subcommittee of the American Academy of Neurology","volume":"86","author":"Simpson","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.jamda.2026.106285_bib51","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1124\/pr.116.012658","article-title":"Botulinum neurotoxins: biology, pharmacology, and toxicology","volume":"69","author":"Pirazzini","year":"2017","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.jamda.2026.106285_bib52","doi-asserted-by":"crossref","first-page":"192","DOI":"10.3389\/fnhum.2015.00192","article-title":"New insights into the pathophysiology of post-stroke spasticity","volume":"9","author":"Li","year":"2015","journal-title":"Front Hum Neurosci"},{"key":"10.1016\/j.jamda.2026.106285_bib53","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1038\/s41582-019-0137-9","article-title":"The role of sensory information in the pathophysiology of focal dystonias","volume":"15","author":"Conte","year":"2019","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.jamda.2026.106285_bib54","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1017\/cjn.2024.46","article-title":"Survey of Canadian physician use of botulinum toxin A (BoNT-A) for paratonia: real world insights","volume":"52","author":"Kleiner","year":"2025","journal-title":"Can J Neurol Sci"},{"key":"10.1016\/j.jamda.2026.106285_bib56","article-title":"Combined botulinum toxin injections and phenol nerve\/motor point blocks to manage multifocal spasticity in adults","volume":"10","author":"Anwar","year":"2017","journal-title":"BJMP"},{"key":"10.1016\/j.jamda.2026.106285_bib57","doi-asserted-by":"crossref","DOI":"10.3389\/fresc.2021.729178","article-title":"Early use of phenol neurolysis likely reduces the total amount of botulinum toxin in management of post-stroke spasticity","volume":"2","author":"Li","year":"2021","journal-title":"Front Rehabil Sci"},{"key":"10.1016\/j.jamda.2026.106285_bib58","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1177\/0269215520963855","article-title":"Can the early use of botulinum toxin in post stroke spasticity reduce contracture development? A randomised controlled trial","volume":"35","author":"Lindsay","year":"2021","journal-title":"Clin Rehabil"},{"key":"10.1016\/j.jamda.2026.106285_bib59","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1177\/0269215511421355","article-title":"An early botulinum toxin A treatment in subacute stroke patients may prevent a disabling finger flexor stiffness six months later: a randomized controlled trial","volume":"26","author":"Hesse","year":"2012","journal-title":"Clin Rehabil"},{"key":"10.1016\/j.jamda.2026.106285_bib60","series-title":"Spasticity: Disordered Motor Control","first-page":"485","year":"1980"},{"key":"10.1016\/j.jamda.2026.106285_bib61","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/354906","article-title":"Pathophysiology of spasticity: implications for neurorehabilitation","volume":"2014","author":"Trompetto","year":"2014","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.jamda.2026.106285_bib62","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1007\/s00221-016-4854-7","article-title":"Electromyographic assessment of paratonia","volume":"235","author":"Marinelli","year":"2017","journal-title":"Exp Brain Res"},{"key":"10.1016\/j.jamda.2026.106285_bib63","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1017\/S1041610207006424","article-title":"Diagnosing paratonia in the demented elderly: reliability and validity of the Paratonia Assessment Instrument (PAI)","volume":"20","author":"Hobbelen","year":"2008","journal-title":"Int Psychogeriatr"},{"key":"10.1016\/j.jamda.2026.106285_bib64","article-title":"Dementia content and delivery in physiotherapy curricula: an international study of entry level physiotherapy programmes in Ireland the United Kingdom and New Zealand","volume":"125","author":"O'Sullivan","year":"2024","journal-title":"Physiotherapy"},{"key":"10.1016\/j.jamda.2026.106285_bib65","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1176\/ajp.132.9.893","article-title":"Psychiatry and the elderly: an overview","volume":"132","author":"Butler","year":"1975","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.jamda.2026.106285_bib66","doi-asserted-by":"crossref","DOI":"10.1002\/ccr3.4148","article-title":"Therapeutic nihilism is inadequate in geriatric medicine","volume":"9","author":"Nau","year":"2021","journal-title":"Clin Case Rep"},{"key":"10.1016\/j.jamda.2026.106285_bib67","article-title":"Alzheimer's disease drug development pipeline: 2022","volume":"8","author":"Cummings","year":"2022","journal-title":"Alzheimers Dement (N Y)"},{"key":"10.1016\/j.jamda.2026.106285_bib76","series-title":"National Guidelines","article-title":"Spasticity in Adults: Management Using Botulinum Toxin","year":"2018"},{"key":"10.1016\/j.jamda.2026.106285_bib80","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1111\/imj.16300","article-title":"Statement of the Rehabilitation Medicine Society of Australia and New Zealand for the therapeutic use of botulinum toxin A in spasticity management","volume":"54","author":"Gupta","year":"2024","journal-title":"Intern Med J"},{"key":"10.1016\/j.jamda.2026.106285_bib81","series-title":"Ontario Drug Benefit Formulary\/Comparative Drug Index","year":"2023"},{"key":"10.1016\/j.jamda.2026.106285_bib84","doi-asserted-by":"crossref","first-page":"E818","DOI":"10.9778\/cmajo.20200234","article-title":"Outreach physiatry clinics in remote Manitoba communities: an economic cost analysis","volume":"9","author":"Reid","year":"2021","journal-title":"CMAJ Open"},{"key":"10.1016\/j.jamda.2026.106285_bib85","author":"Khan"},{"key":"10.1016\/j.jamda.2026.106285_bib87","first-page":"65","article-title":"On the care situation for patients with spastic movement disorder in Germany","volume":"12","author":"Potempa","year":"2019","journal-title":"MVF"},{"key":"10.1016\/j.jamda.2026.106285_bib88","article-title":"Die Versorgungssituation von Patient:innen mit spastischer Bewegungsst\u00f6rung in Deutschland: ein Vergleich (II)","volume":"15","author":"V\u00f6lkel","year":"2022","journal-title":"MVF"},{"key":"10.1016\/j.jamda.2026.106285_bib89","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s00115-023-01571-8","article-title":"[Improvement of the treatment of patients with spastic movement disorder after stroke]","volume":"95","author":"Lee","year":"2024","journal-title":"Nervenarzt"},{"key":"10.1016\/j.jamda.2026.106285_bib90","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0190392","article-title":"Healthcare costs for the elderly in Japan: analysis of medical care and long-term care claim records","volume":"13","author":"Akiyama","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.jamda.2026.106285_bib91","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000548679","article-title":"Botulinum toxin underuse in older stroke survivors with spasticity: a nationwide population-based cohort study","author":"Ojardias","year":"2025","journal-title":"Neuroepidemiology"},{"key":"10.1016\/j.jamda.2026.106285_bib92","article-title":"Arr\u00eat\u00e9 du 6 juin 2024 modifiant l'arr\u00eat\u00e9 du 19 d\u00e9cembre 2022 relatif \u00e0 l'exp\u00e9rimentation \u00ab AUTO-NOM \u00bb (neuro-orthop\u00e9die mobile)","year":"2024","journal-title":"J Officiel R\u00e9pub Fr"},{"key":"10.1016\/j.jamda.2026.106285_bib93","series-title":"Improving the Quality of Care in Nursing Homes","year":"1986"},{"key":"10.1016\/j.jamda.2026.106285_bib99","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1212\/WNL.0b013e318294b1cf","article-title":"Supply and demand analysis of the current and future US neurology workforce","volume":"81","author":"Dall","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.jamda.2026.106285_bib100","first-page":"34","article-title":"The ever-changing field of physical medicine and rehabilitation","volume":"114","author":"Worsowicz","year":"2017","journal-title":"Mo Med"},{"issue":"suppl","key":"10.1016\/j.jamda.2026.106285_bib101","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1212\/WNL.94.15_supplement.727","article-title":"Geographical distribution of neurologists in the United States (727)","volume":"94","author":"Curtis","year":"2020","journal-title":"Neurology"},{"key":"10.1016\/j.jamda.2026.106285_bib103","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1111\/jgs.16054","article-title":"Care settings and clinical characteristics of older adults with moderately severe dementia","volume":"67","author":"Harrison","year":"2019","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.jamda.2026.106285_bib105","author":"Carpenter"},{"key":"10.1016\/j.jamda.2026.106285_bib107","doi-asserted-by":"crossref","first-page":"441","DOI":"10.7326\/0003-4819-158-6-201303190-00003","article-title":"Access to subspecialty care for patients with mobility impairment: a survey","volume":"158","author":"Lagu","year":"2013","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jamda.2026.106285_bib108","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.dhjo.2012.02.002","article-title":"Physical accessibility in primary health care settings: results from California on-site reviews","volume":"5","author":"Mudrick","year":"2012","journal-title":"Disabil Health J"},{"key":"10.1016\/j.jamda.2026.106285_bib109","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1177\/0733464813505701","article-title":"Dementia in relation to family caregiver involvement and burden in long-term care","volume":"33","author":"Cohen","year":"2014","journal-title":"J Appl Gerontol"},{"key":"10.1016\/j.jamda.2026.106285_bib110","article-title":"Botulinum toxin market research report: by product type, by application, by end user, and by region \u2013 forecast to 2032","year":"2024","journal-title":"Persistence Market Res"},{"key":"10.1016\/j.jamda.2026.106285_bib112","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1111\/iwj.13071","article-title":"The national cost of hospital-acquired pressure injuries in the United States","volume":"16","author":"Padula","year":"2019","journal-title":"Int Wound J"},{"key":"10.1016\/j.jamda.2026.106285_bib113","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1186\/1472-6963-8-277","article-title":"Reliability of the interRAI suite of assessment instruments: a 12-country study of an integrated health information system","volume":"8","author":"Hirdes","year":"2008","journal-title":"BMC Health Serv Res"},{"key":"10.1016\/j.jamda.2026.106285_bib116","doi-asserted-by":"crossref","first-page":"215","DOI":"10.12968\/ijtr.2018.25.5.215","article-title":"Spasticity management with botulinum toxin: a comparison of UK physiotherapy and rehabilitation medicine injectors","volume":"25","author":"Ashford","year":"2018","journal-title":"Int J Ther Rehabil"},{"key":"10.1016\/j.jamda.2026.106285_bib127","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/nrd.2018.168","article-title":"Drug repurposing: progress, challenges and recommendations","volume":"18","author":"Pushpakom","year":"2019","journal-title":"Nat Rev Drug Discov"}],"container-title":["Journal of the American Medical Directors Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525861026001751?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525861026001751?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T00:45:50Z","timestamp":1785977150000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525861026001751"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":89,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S1525861026001751"],"URL":"https:\/\/doi.org\/10.1016\/j.jamda.2026.106285","relation":{},"ISSN":["1525-8610"],"issn-type":[{"value":"1525-8610","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Paratonia in Advanced Dementia: Deconstructing Scientific, Regulatory, and Health System Barriers to Botulinum Toxin A (BoNT-A) Treatment of Involuntary Muscle Resistance","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Medical Directors Association","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jamda.2026.106285","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of Post-Acute and Long-Term Care Medical Association.","name":"copyright","label":"Copyright"}],"article-number":"106285"}}